| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |